Governor-Elect Youngkin Announces Medical Advisory Team
RICHMOND — Governor-elect Glenn Youngkin today announced his Medical Advisory Team led by Dr. Marty Makary, Nancy Agee, Kathy Gorman, Alan Levine, Dr. Bogdan Neughebaeur, and Anand Shah.
“I am proud to announce a group of experts from the medical and public health community that will be providing updates on the pandemic and advice on how to address its ongoing challenges. I have been receiving briefings about the coronavirus and Omicron variant regularly and we are going to stay on top of this. I recognize the severity of the virus and the significant loss that it has caused. Virginians should rest assured that we are monitoring this variant and doing everything we can to be smart about this. I will enter office ready to reopen Virginia, support our healthcare heroes, and protect the lives and livelihoods of Virginians,” said Governor-elect Glenn Youngkin.
Ready on Day One with Counsel from Renowned Medical Leaders
- Governor-elect Youngkin has been fully briefed by experts from Health and Human Resources led by John Littel, the Virginia Department of Health, and the Virginia Department of Emergency Management to stay current on the data, science, and emergency response underway to address the Coronavirus pandemic. He will continue to receive frequent updates from his independent, objective Medical Advisory Team, who are experts from the medical and public health community. Governor-elect Youngkin’s Medical Advisory Team includes:
- Chair: Dr. Marty Makary, M.D., M.P.H., Johns Hopkins Medicine
- Nancy Howell Agee, President and CEO, Carilion Clinic
- Kathy Gorman, M.S.N., R.N., F.A.A.N, Executive Vice President and COO, Children’s National
- Alan Levine, Chairman, President and Chief Executive Officer, Ballad Health
- Bogdan Neughebauer, M.D., PhD, MBA, CPE, FACP, FIDSA, Sentara Healthcare
- Anand Shah, M.D., M.P.H., former Deputy Commissioner for Medical and Scientific Affairs at FDA
- Secretary of Health and Human Resources John Littel
- Senator Siobhan Dunnavant
- Senator Todd Pillion
Chair, Dr. Marty Makary, M.D., M.P.H.
Dr. Marty Makary is a surgical oncologist and chief of the Johns Hopkins Islet Transplant Center. He is a clinical lead for the Johns Hopkins Sibley Innovation Hub and serves as Executive Director of Improving Wisely, a Robert Wood Johnson Foundation project to lower health care costs in the U.S. by creating measures of appropriateness in health care.
Dr. Makary’s research focuses on the creation and evaluation of new health care innovations. He is the creator of the Surgery Checklist, publishing its first description and later served on the W.H.O. Safe Surgery Saves Lives committee.
He serves jointly as a professor of surgery at the Johns Hopkins University School of Medicine and a professor of health policy & management at the Johns Hopkins Bloomberg School of Public Health.
Dr. Makary is a graduate of Bucknell, Thomas Jefferson and Harvard University. He completed his surgical training at Georgetown University and his fellowship at Johns Hopkins Hospital.
Dr. Makary has published over 250 scientific articles on the re-design of health care, medical innovation, and vulnerable populations. Dr. Makary has been elected to the National Academy of Medicine and is Editor-in-Chief of Medpage Today.
He is a Fox News Contributor who shares his expertise on NPR and has written for The Wall Street Journal, The New York Times, and USA Today and is a frequent medical commentator.
Nancy Agee, President and CEO, Carilion Clinic
Nancy Agree is President and CEO of Carilion Clinic, a $2.4 billion not-for-profit health care system headquartered in Roanoke, Virginia; serving over 1 million people in Virginia and West Virginia. Carilion Clinic is organized as a large physician group with more than 1,000 employed physicians, an academic medical center and 7 hospitals ranging from a large, tertiary/quaternary medical center, Level 1 Trauma Center and teaching hospital to a Children’s Hospital to midsized community hospitals to small rural or critical access hospitals as well as multiple business lines such as Home Health, Imaging Services, Pharmacies and Urgent Care.
Ms. Agee was the Executive Vice President and Chief Operating Officer before becoming CEO. She co-led Carilion’s transformation from a collection of hospitals to a patient-centered, physician-led organization. The reorganization included a public/private partnership with Virginia Tech to create an allopathic medical school and a research institute.
Ms. Agee is a nationally recognized leader in healthcare, immediate past chair of the American Hospital Association (a membership organization representing the nation’s 5000 hospitals). She has been perennially named one of the Top 100 Most Influential People in Healthcare by Modern Healthcare as well as to the Top 25 Woman in Healthcare. Ms. Agee is a former member of The Board of Commissioners for the Joint Commission (international hospital accreditation organization) and past chair of the Virginia Hospital and Healthcare Association and the Virginia Center for Health Innovation.
Ms. Agee was named Virginia Business Person of the year in 2017 by Virginia Business and has been on the list of most influential persons in Virginia for the past nine years. She was also named Virginia Business Magazine’s Virginia 500 – the 2020 Power List.
She is a member of The Wall Street Journal Council of CEOs, Virginia Foundation for Independent Colleges, Virginia Business Council, Virginia Business Higher Education Council and on the Governor’s Advisory Council on Revenue Estimates. She is a Fellow in the National Association of Corporate Directors.
Ms. Agee received her undergraduate degree from University of Virginia and her graduate degree from Emory University; and continued postgraduate studies at the Kellogg School of Business, Northwestern University. She received honorary Doctorate of Humane Letters, from both Roanoke College and Jefferson College of Health Sciences in 2015.
Kathy Gorman, MSN, RN, FAAN, Executive Vice President and COO, Children’s National Hospital
Kathleen Chavanu is Executive Vice President of Patient Care Services and Chief Operating Officer since 2012. Kathy is a nurse leader who has advanced strategic priorities to transform patient safety, quality, clinical care and operations to improve outcomes for children and families.
Previously Kathy served as the Senior Vice President of Patient Care Services and Chief Nursing Officer the Children’s Hospital of Philadelphia (CHOP), and Assistant Dean of Clinical Practice at the University of Pennsylvania School of Nursing. Prior to her tenure at CHOP, Kathy was at Children’s National as Vice President of Quality and Clinical Support Services for over a decade.
Kathy has presented and published extensively on quality, safety, outcomes and leadership in healthcare. In advancing the national agenda on improving child health through pediatric quality, she has led and participated in committees under the American Hospital Association (AHA), National Quality Forum, The Leapfrog Group, Children’s Hospital Association (CHA), American Board of Pediatrics, Institute of Medicine and others. She currently serves as the Treasurer for the American Academy of Nursing, Chair of the Healthcare Council of National Capital Area, is on the Board of Directors for The DAISY Foundation and the Education Council for CHA, and other advisory boards.
Kathy was the recipient of the distinguished Alumni Award for the University of Nebraska Medical Center. She received the AHA’s Grassroots Champion Award for Washington, DC, in recognition of her advocacy on behalf of patients, hospitals and communities. She has been recognized as a top woman leader by Becker’s Hospital Review and as a Washington, D.C. “Women Who Mean Business” top leader. Kathy is a Fellow in the American Academy of Nursing and a Leadership Greater Washington alumni.
Alan Levine, Executive Chairman, President, and CEO, Ballad Healthcare
Alan Levine, Chairman, President, and CEO of Ballad Healthcare (SWVA), previously served as Governor Jeb Bush’s Secretary of Healthcare Administration and worked for Gov. Jindal as Secretary of Department of Health and Hospitals. He also served as Gov. Jeb Bush’s Deputy Chief of Staff.
With more than 25 years of hospital operations experience, Mr. Levine has served as chief executive officer of hospitals and health systems ranging from a small rural hospital to one of the largest public systems in America. Prior to his role at Ballad Health, He was the president and chief executive officer of Mountain States Health Alliance. Mr. Levine served on Louisiana governor Bobby Jindal’s cabinet as secretary of Louisiana’s Department of Health and Hospitals and as Governor Jindal’s senior health policy advisor.
Mr. Levine also served as deputy chief of staff and senior health policy advisor to Florida governor Jeb Bush prior to his appointment by Governor Bush to serve as secretary of Florida’s Agency for Health Care Administration, an agency responsible for administering a $17 billion budget. In these roles, he oversaw the health care response to 12 major hurricanes making landfall in Florida and Louisiana, managed Louisiana’s response to the H1N1 Influenza Pandemic, led Louisiana’s effort to improve child immunization rates from ranking 48th in the nation to 2nd, successfully advocated the passage of major and historic health care reforms in both states and was recognized for his efforts in combating fraud and abuse in public health care programs.
Mr. Levine currently serves on the board of governors of the State University System of Florida, the governing body of Florida’s 12 state universities.
Recognized by Modern Healthcare magazine as one of the 30 Americans likely to have a powerful impact on health care in the next 30 years, and as an up-and-comer in the health care industry, Mr. Levine is widely recognized in the health care industry. Most recently, he was recognized as a Junior Achievement Laureate and named to the Business Hall of Fame in upper East Tennessee.
He received a bachelor’s degree in health sciences, a master’s degree in business administration and a master’s degree in health sciences from the University of Florida, where he is recognized as a member of the University of Florida Hall of Fame. He is married to his wife, Laura, a nurse, and they have two grown children, both with careers in health care.
Dr. Bogdan Neughebauer, M.D., PhD, MBA, CPE, FACP, FIDSA, Sentara Healthcare
Dr. Bogdan Neughebauer has served as the Vice President of Medical Affairs at Sentara Leigh Hospital in Norfolk, Virginia, since February 2021. He attended medical school in his native country of Romania and graduated as valedictorian of his class.
He was an infectious disease specialist with Sentara Medical Group from 2003 through 2021, where he also served as the Chair of Finance and Chair of Board of Directors. He has significant experience as a physician leader including roles such as Medical Director of the Sentara Antimicrobial Stewardship Program, Chair of the Sentara Infection Prevention High Performance Team, Physician Executive Sponsor of the Sentara ICD 10 Project and Lead Infectious Disease Physician on Sentara COVID Task Force.
After receiving the title of Certified Physician Executive, Dr. Neughebauer obtained his Master of Business Administration from the University of Massachusetts, Amherst, and was elected in the Beta Gamma Sigma society. He has been the recipient of many awards including the Southgate Leigh Physician Excellence Award, Sentara CEO Award, and Top Hampton Roads doctor.
Dr. Anand Shah, M.D., former FDA Deputy Commissioner for Medical and Scientific Affairs
Anand Shah, M.D. is a nationally recognized physician leader and health policy expert who most recently served as the Deputy Commissioner for Medical and Scientific Affairs at the U.S. Food and Drug Administration (FDA). Dr. Shah’s efforts have focused on bringing new technologies to market, redesigning health care delivery and economic incentives, and expanding competition and consumer choice. At FDA, Dr. Shah led consensus policy development for fit-for-purpose programs including pandemic recovery and preparedness, Advanced Manufacturing, the Coronavirus Treatment Acceleration Program, COVID-19 vaccine development, digital health, consumer protection, and decentralized clinical trials. He developed a science and technology incubator designed to harness real-world evidence and artificial intelligence to improve health outcomes. Dr. Shah represented FDA with top-level policy makers of the White House and Cabinet, Governors, and local governments. He regularly briefed bipartisan bicameral Congressional leadership on the formulation of public health policies and programs.
He previously served in two senior leadership roles at the Centers for Medicare & Medicaid Services (CMS). As Senior Medical Advisor, he was the primary counselor for agency-wide policy related to medical and scientific innovation. Dr. Shah established consensus on several critical policy initiatives including aligning payment and prevention to increase Medicare beneficiaries’ access to novel antimicrobials, expanding patients’ access to cell and gene therapies, and streamlining Medicare access to breakthrough technologies. As the Chief Medical Officer of the Center for Medicare & Medicaid Innovation (CMMI), Dr. Shah led the clinical design of novel value-based payment and service delivery models including those for advanced primary care, specialty care, and prescription drugs.
Dr. Shah specializes in the early detection, surveillance, and treatment of prostate cancer. He developed and led a survivorship clinic for the care of patients on cancer clinical trials at the National Institutes of Health. He concurrently earned his M.D. from the University of Pennsylvania and an M.P.H. in health care management and policy from the Harvard School of Public Health. Dr. Shah graduated with honors from Duke University with a degree in economics. He also served as a Canada-U.S. Fulbright Scholar.